Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

100%

3 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
P 3 (2)
P 4 (1)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT01787110Phase 3Completed

An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction

NCT02290080Phase 3Completed

Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers

NCT01694459Phase 4Unknown

DEDICA (Dose of HEparin During Coronary Angioplasty) Trial

Showing all 3 trials

Research Network

Activity Timeline